Atlas Trials

Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant

Clinical trial NCT00476177 · COMPLETED

Trial details

NCT number
NCT00476177
Sponsor
Dana-Farber Cancer Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hematologic Malignancy
Start date
2003-07-01
Primary completion
2007-08-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.